Daiwa Securities Group Inc. Acquires 1,106 Shares of Teleflex Incorporated (NYSE:TFX)

Daiwa Securities Group Inc. boosted its holdings in Teleflex Incorporated (NYSE:TFX) by 10.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,295 shares of the medical technology company’s stock after purchasing an additional 1,106 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Teleflex were worth $2,793,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in TFX. Cromwell Holdings LLC lifted its holdings in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares in the last quarter. Avior Wealth Management LLC increased its holdings in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares during the last quarter. Ashton Thomas Securities LLC purchased a new stake in Teleflex in the 3rd quarter worth $40,000. Canada Pension Plan Investment Board bought a new position in shares of Teleflex during the 2nd quarter valued at about $42,000. Finally, GAMMA Investing LLC grew its position in shares of Teleflex by 131.1% during the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after purchasing an additional 97 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

Teleflex stock opened at $192.00 on Thursday. The firm has a market capitalization of $8.92 billion, a PE ratio of 38.17, a price-to-earnings-growth ratio of 1.99 and a beta of 1.18. Teleflex Incorporated has a 12-month low of $185.66 and a 12-month high of $257.85. The firm has a 50-day moving average price of $221.96 and a 200-day moving average price of $222.66. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same quarter in the previous year, the business earned $3.64 earnings per share. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. As a group, equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.71%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Analyst Upgrades and Downgrades

TFX has been the topic of a number of research analyst reports. Stephens boosted their target price on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday. Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.